Sage Mountain Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,944
Closed -$646K 492
2025
Q4
$646K Sell
25,944
-1,013
-4% -$25.5K 0.03% 237
2025
Q3
$687K Buy
26,957
+4,168
+18% +$103K 0.04% 216
2025
Q2
$552K Buy
22,789
+7,322
+47% +$171K 0.04% 225
2025
Q1
$392K Sell
15,467
-5,120
-25% -$134K 0.03% 257
2024
Q4
$546K Buy
20,587
+1,404
+7% +$38.1K 0.04% 195
2024
Q3
$555K Buy
19,183
+6,185
+48% +$180K 0.05% 184
2024
Q2
$364K Sell
12,998
-819
-6% -$22.5K 0.03% 220
2024
Q1
$383K Sell
13,817
-3,091
-18% -$85.8K 0.04% 198
2023
Q4
$487K Sell
16,908
-6,255
-27% -$189K 0.06% 134
2023
Q3
$768K Sell
23,163
-2,711
-10% -$95.9K 0.11% 86
2023
Q2
$949K Buy
25,874
+743
+3% +$28.9K 0.14% 74
2023
Q1
$1.03M Buy
25,131
+10,108
+67% +$437K 0.17% 63
2022
Q4
$770K Buy
15,023
+3,081
+26% +$148K 0.18% 52
2022
Q3
$523K Sell
11,942
-68
-0.6% -$3.3K 0.14% 63
2022
Q2
$630K Buy
12,010
+659
+6% +$33.6K 0.11% 174
2022
Q1
$588K Sell
11,351
-1,166
-9% -$60.5K 0.09% 233
2021
Q4
$739K Buy
12,517
+748
+6% +$37.1K 0.09% 215
2021
Q3
$506K Buy
11,769
+16
+0.1% +$709 0.07% 257
2021
Q2
$460K Buy
11,753
+1,803
+18% +$70.1K 0.08% 244
2021
Q1
$360K Buy
9,950
+2,864
+40% +$102K 0.08% 204
2020
Q4
$261K Buy
+7,086
New +$260K 0.09% 148

Other funds holding PFE

Sage Mountain Advisors's PFE Position: Q1 2026 in Review

Sage Mountain Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 25,944 shares — an estimated $646K sold.

Sage Mountain Advisors first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $1.03M in Q1 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sage Mountain Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Sage Mountain Advisors sold 25,944 Pfizer shares in Q1 2026, an estimated $646K.
  • Sage Mountain Advisors first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
  • Sage Mountain Advisors's Pfizer position peaked at $1.03M in Q1 2023.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.